InvestorsHub Logo
Followers 1
Posts 307
Boards Moderated 0
Alias Born 07/24/2015

Re: None

Wednesday, 09/26/2018 9:31:23 AM

Wednesday, September 26, 2018 9:31:23 AM

Post# of 430369
Another major x-factor still in play that I’m surprised few have mentioned: indications beyond CVD.

For the trial experts out there, is it possible that some of the added SEs could be ‘feelers’ to guide AMRN in researching other uses for their new superdrug?

Part of me wonders if pursuit of further indications will be worthwhile simply due to the supply/demand constraints.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News